Wed, 26 Feb 2020 13:13:21: How targeting tumor blood vessels may help overcome treatment resistance in glioblastoma

Wed, 26 Feb 2020 10:33:57: Takeda buys PvP in $330M deal to bag a 2nd celiac drug

Wed, 26 Feb 2020 09:56:56: Vanda Pharmaceuticals shares in the red as skin disease test fails

Wed, 26 Feb 2020 09:32:17: Iovance shares jump on buyout rumors

Tue, 25 Feb 2020 16:14:37: MPM gains first offer on Dana-Farber tech, raises $100M fund

Tue, 25 Feb 2020 14:13:12: Kahr raises $18M to test CD47 drug with Roche's Tecentriq

Tue, 25 Feb 2020 13:27:36: Genentech pays Bicycle $30M upfront to form discovery-stage immuno-oncology pact

Tue, 25 Feb 2020 10:29:57: Harvard, Guangzhou Institute nab $115M for fight against COVID-19

Tue, 25 Feb 2020 09:08:56: Moderna wins bragging rights as it kick-starts first experimental coronavirus clinical trial

Mon, 24 Feb 2020 13:44:10: Grifols buys antibiotic assets from bankrupt partner Aradigm

Mon, 24 Feb 2020 13:02:53: Repurposing Astellas' and Novartis' leukemia drugs in resistant lung cancer

Mon, 24 Feb 2020 12:34:52: Kadmon drops detailed look at cGVHD data; analysts see 'underappreciated potential'

Mon, 24 Feb 2020 10:15:48: GSK gives Clover adjuvant for vaccine against 'indispensable' COVID-19 protein

Fri, 21 Feb 2020 12:42:33: Effector co-founder leaves to take up CSO post at Turning Point

Fri, 21 Feb 2020 12:29:37: BioMarin gene therapy won't need an AdComm as it nabs speedy FDA review

Fri, 21 Feb 2020 11:18:21: Spark R&D chief High exits in wake of Roche takeover

Fri, 21 Feb 2020 09:03:01: Genfit's NASH key phase 3 data delayed

Thu, 20 Feb 2020 21:32:50: Chutes & Ladders—Scholefield out as Merck & Co. digital head

Thu, 20 Feb 2020 14:11:01: A CRISPR cure for cystic fibrosis?

Thu, 20 Feb 2020 13:08:37: Everest hires ex-Lilly leader to oversee push for Chinese market

Thu, 20 Feb 2020 03:49:07: Thymus atlas could spark new treatments for cancer, autoimmune disease

Wed, 19 Feb 2020 16:40:09: GSK pays $50M for 2 solid tumor cell therapies from Immatics

Wed, 19 Feb 2020 13:49:06: Incyte hits endpoint in 2nd pivotal atopic dermatitis trial

Wed, 19 Feb 2020 12:56:30: How a discovery in 'junk' DNA could protect against heart disease

Wed, 19 Feb 2020 09:32:29: Israeli biotech NeoTX lands $45M series C for combo I-O cancer trials